Johnson & Johnson logo

Johnson & Johnson (JNJ)

Market Closed
13 Mar, 11:55
COL$
683,660. 00
-16,340
-2.33%
COL$
356.43B Market Cap
29.06 P/E Ratio
4.96% Div Yield
8 Volume
9.91 Eps
COL$ 700K
Previous Close
Day Range
683,660 683,660
Year Range
580,420 717,320
Earnings results expected in 29 days

Summary

JNJ closed Thursday lower at COL$683,660, a decrease of 2.33% from Wednesday's close, completing a monthly increase of 7.07% or COL$45,160. Over the past 12 months, JNJ stock lost -0.21%.
JNJ pays dividends to its shareholders, with the most recent payment made on Mar 04, 2025. The next estimated payment will be in In 2 months on Jun 04, 2025 for a total of COL$1.24.
The last earnings report, released on Jan 22, 2025, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0.08%, based on the last three reports. The next scheduled earnings report is due on Apr 14, 2025.
The stock of the company had never split.
The company's stock is traded on 18 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track JNJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

JNJ Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Johnson & Johnson (JNJ) FAQ

What is the stock price today?

The current price is COL$683,660.00.

On which exchange is it traded?

Johnson & Johnson is listed on NYSE.

What is its stock symbol?

The ticker symbol is JNJ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 356.43B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 14, 2025.

Has Johnson & Johnson ever had a stock split?

No, there has never been a stock split.

Johnson & Johnson Profile

Engineering & Construction Industry
Industrials Sector
Mr. Roberto Cecatto CEO
BVC Exchange
US4781601046 ISIN
Italy Country
600 Employees
18 Feb 2025 Last Dividend
- Last Split
- IPO Date

Overview

Johnson & Johnson, a renowned entity in the healthcare sector, operates globally with a broad focus on research, development, manufacturing, and sales of healthcare products. The company is structured in multiple segments, primarily Innovative Medicine and MedTech, catering to a vast array of therapeutic areas and medical needs. Founded in 1886, the company is headquartered in New Brunswick, New Jersey, illustrating a longstanding presence and commitment to healthcare innovation and advancement. Through its extensive product line and diversified service offerings, Johnson & Johnson reaches a wide audience, including retailers, wholesalers, distributors, hospitals, and healthcare professionals, providing prescription and non-prescription products alike.

Products and Services

The company's portfolio is divided into two main segments, each encompassing a variety of products and services designed to meet the complex demands of modern healthcare:

  • Innovative Medicine:

    This segment includes a range of products for different therapeutic areas. These encompass immunology (covering diseases like rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis), infectious diseases (including HIV/AIDS treatment), neuroscience (targeting mood disorders, neurodegenerative disorders, schizophrenia), oncology (focused on cancers such as prostate, lung, bladder, and hematologic malignancies), cardiovascular and metabolism (addressing conditions like thrombosis, diabetes, and macular degeneration), and pulmonary hypertension, specifically pulmonary arterial hypertension.

  • MedTech:

    This segment offers products and technologies across a range of medical fields. Interventional Solutions include electrophysiology products for heart rhythm disorders and technologies for severe coronary artery disease treatment. The neurovascular care line focuses on treating hemorrhagic and ischemic strokes. Orthopaedics products support treatments for hips, knees, trauma, spine, and sports injuries. The surgery portfolio covers advanced and general surgery technologies and solutions for breast aesthetics and ear, nose, and throat procedures. Additionally, MedTech offers visual health products like ACUVUE Brand contact lenses and TECNIS intraocular lenses for cataract surgery.

Contact Information

Address: Via Teulada 66
Phone: 39 06 87 16 57 50